G. Michael Landis
Chief Financial Officer, Director · Polaryx Therapeutics, Inc.
- 2026
- Feb 20, 2026
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies G. Michael Landis files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Alex Keun Mo Yang - $360K in PLYX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is G. Michael Landis?
G. Michael Landis is a corporate insider, tracked as Chief Financial Officer, Director of Polaryx Therapeutics, Inc. (PLYX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did G. Michael Landis last file a Form 4?
The only primary Form 4 on record is dated 20 February 2026.
Has G. Michael Landis been buying or selling stock?
Recorded transactions: 1 open-market purchase ($8K) and 0 open-market sales across all tracked filings.
